Norway Non-opioid Pain Treatment Market Size & Outlook
Norway non-opioid pain treatment market, 2018-2030 (US$M)
Related Markets
Norway non-opioid pain treatment market highlights
- The Norway non-opioid pain treatment market generated a revenue of USD 389.7 million in 2024 and is expected to reach USD 570.5 million by 2030.
- The Norway market is expected to grow at a CAGR of 6.7% from 2025 to 2030.
- In terms of segment, nsaids was the largest revenue generating drug class in 2024.
- Other Drug Class is the most lucrative drug class segment registering the fastest growth during the forecast period.
Non-opioid pain treatment market data book summary
| Market revenue in 2024 | USD 389.7 million |
| Market revenue in 2030 | USD 570.5 million |
| Growth rate | 6.7% (CAGR from 2025 to 2030) |
| Largest segment | Nsaids |
| Fastest growing segment | Other Drug Class |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acetaminophen, Local Anesthetics, Other Drug Class, NSAIDs |
| Key market players worldwide | Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, GSK PLC ADR, Pfizer Inc, Perrigo Co PLC, LNK International Inc., Cipla Ltd DR, Johnson & Johnson, Pacira BioSciences Inc, Pierrel S.p.A |
Other key industry trends
- Country-wise, France is expected to lead the global market in terms of revenue in 2030.
- In Europe, France non-opioid pain treatment market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 2,442.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-opioid Pain Treatment Market Scope
Non-opioid Pain Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway non-opioid pain treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-opioid pain treatment market will help companies and investors design strategic landscapes.
Nsaids was the largest segment with a revenue share of 57.51% in 2024. Horizon Databook has segmented the Norway non-opioid pain treatment market based on acetaminophen, local anesthetics, other drug class, nsaids covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Norway non-opioid pain treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway non-opioid pain treatment market databook
-
Our clientele includes a mix of non-opioid pain treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway non-opioid pain treatment market , including forecasts for subscribers. This country databook contains high-level insights into Norway non-opioid pain treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway non opioid pain treatment market report size, by drug class, 2018-2030 (US$M)
Norway Non-opioid Pain Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
